Hepatitis C Virus-Core Antigen: Implications in Diagnostic, Treatment Monitoring and Clinical Outcomes

Duong Hoang Huy Le1,2,3, Sitthichai Kanokudom1,2, Ha Minh Nguyen3,4

  • 1Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.

Viruses
|January 8, 2025
PubMed

Insights

Hepatitis C virus core antigen (HCVcAg) testing is a cost-effective method for diagnosing active infections and monitoring treatment, especially in resource-limited areas. This approach aids in managing liver disease progression and risk assessment for hepatitis C care.

Area of Science:

  • Hepatology
  • Virology
  • Clinical Diagnostics

Background:

  • Hepatitis C virus (HCV) infection is a significant global health issue leading to chronic liver disease.
  • HCV core antigen (HCVcAg) is crucial for viral replication and presents a cost-effective diagnostic alternative.
  • Current diagnostic methods like HCV RNA assays can be expensive, limiting access in resource-limited settings.

Purpose of the Study:

  • To review the significance, structure, function, and life cycle role of HCV core antigen.
  • To evaluate the clinical utility of HCVcAg assays for diagnosis and treatment monitoring.
  • To compare the performance of HCVcAg assays against standard HCV RNA assays.

Main Methods:

  • Literature review of studies from PubMed and Google Scholar.
  • Analysis of HCV core antigen structure, function, and viral life cycle role.
  • Comparative performance evaluation of HCVcAg assays versus HCV RNA assays.

Main Results:

  • HCVcAg assays demonstrate high pooled sensitivity (93.5%) and specificity (99.2%) compared to HCV RNA assays.
  • HCVcAg levels show a strong correlation (r = 0.87) with HCV RNA levels.
  • HCVcAg testing effectively predicts liver disease progression and assesses risks for fibrosis and carcinoma.

Conclusions:

  • HCVcAg testing is a viable, cost-effective tool for diagnosing active HCV infections and monitoring treatment, particularly in resource-limited settings.
  • While effective, standardization and addressing sensitivity variations are necessary for HCVcAg assays.
  • HCVcAg testing can improve patient management, expand access to care, and support global HCV elimination efforts.

Related Concept Videos

Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
79
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
429
Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
150
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
70
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
34
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
64